by James Radke | Apr 5, 2021
Shruti Chaturvedi, MBBS, MS, Assistant Professor of Medicine at Johns Hopkins provides an overview of thrombotic thrombocytopenic purpura (TTP). TTP is a rare hematologic condition due to reduced activity of ADAMTS13 enzyme. The reduced activity is either due...
by James Radke | Mar 25, 2021
X. Long Zheng, MD, PhD, of the Department of Pathology and Laboratory Medicine at the University of Kansas Medical Center, provides an overview of thrombotic thrombocytopenic purpura (TTP) and why lengthy hospital stays are necessary. TTP is a rare hematologic...
by James Radke | Mar 18, 2021
Kimberly Cockerham, MD, Adjunct Clinical Associate Professor, Stanford Department of Ophthalmology, talks about quality of life concerns in people with thyroid eye disease (TED). TED is a condition that often occurs in persons with Graves disease – a rare...
by James Radke | Mar 4, 2021
Andrew M. Evens, DO, Director of the Lymphoma Program at Rutgers Cancer Institute and Medical Director of the Oncology Service Line at RWJBarnabas Health, talks about New Prognostic Indicator for Burkitt Lymphoma. Burkitt lymphoma is a rare, and very...
by James Radke | Feb 26, 2021
Matheus Wilke of the Hospital de Clinicas de Porta Alegre in Brazil, explains the origins of their booklet to educate children about enzyme replacement therapy (ERT) during the Covid-19 pandemic. As Mr. Wilke explains, the pandemic resulted in new safety...
